Published in BMC Mol Biol on May 20, 2010
The leukemia associated nuclear corepressor ETO homologue genes MTG16 and MTGR1 are regulated differently in hematopoietic cells. BMC Mol Biol (2012) 0.78
SMIM1 variants rs1175550 and rs143702418 independently modulate Vel blood group antigen expression. Sci Rep (2017) 0.75
Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1. PLoS One (2015) 0.75
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature (2000) 16.75
A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res (1991) 13.54
Applied bioinformatics for the identification of regulatory elements. Nat Rev Genet (2004) 9.96
Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol (2002) 6.88
Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev (1994) 5.22
Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci U S A (1996) 5.20
Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene (2002) 4.80
A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J (1997) 4.61
Molecular biology of the Ets family of transcription factors. Gene (2003) 4.41
Global regulation of erythroid gene expression by transcription factor GATA-1. Blood (2004) 4.22
Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol Cell Biol (1997) 4.12
Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages. Nature (1990) 3.96
DNA-binding specificities of the GATA transcription factor family. Mol Cell Biol (1993) 3.91
ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci U S A (1998) 3.59
The GATA family (vertebrates and invertebrates). Curr Opin Genet Dev (2002) 3.39
GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci U S A (2003) 3.32
Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol (1998) 3.13
ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol (1998) 3.06
The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J (1993) 3.00
Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood (1999) 2.61
ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol (2001) 2.60
GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol (2005) 2.55
GATA-1-mediated proliferation arrest during erythroid maturation. Mol Cell Biol (2003) 2.52
E protein silencing by the leukemogenic AML1-ETO fusion protein. Science (2004) 1.89
Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. EMBO J (2002) 1.84
ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis. Mol Cell Biol (2005) 1.70
Dynamics of GATA transcription factor expression during erythroid differentiation. Blood (1993) 1.69
Repression of c-kit and its downstream substrates by GATA-1 inhibits cell proliferation during erythroid maturation. Mol Cell Biol (2005) 1.67
The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood (1998) 1.64
Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development. Blood (2005) 1.64
ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. EMBO J (2006) 1.63
The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol Cell Biol (1998) 1.58
Transcriptional control of erythropoiesis: emerging mechanisms and principles. Oncogene (2007) 1.52
Identification of homeotic target genes in Drosophila melanogaster including nervy, a proto-oncogene homologue. Genetics (1995) 1.48
The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein. Mol Cell Biol (2000) 1.33
Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation. Mol Cell Biol (2008) 1.29
Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism. J Cell Biochem (2003) 1.26
Oligomerization of ETO is obligatory for corepressor interaction. Mol Cell Biol (2001) 1.22
ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein. Blood (2003) 1.19
Multiple regions of ETO cooperate in transcriptional repression. J Biol Chem (2001) 1.18
AML1/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets. PLoS Genet (2008) 1.17
Mtgr1 is a transcriptional corepressor that is required for maintenance of the secretory cell lineage in the small intestine. Mol Cell Biol (2005) 1.16
Gene targeting reveals a crucial role for MTG8 in the gut. Mol Cell Biol (2001) 1.14
Erythroid inhibition by the leukemic fusion AML1-ETO is associated with impaired acetylation of the major erythroid transcription factor GATA-1. Cancer Res (2006) 1.08
Characterization of megakaryocyte GATA1-interacting proteins: the corepressor ETO2 and GATA1 interact to regulate terminal megakaryocyte maturation. Blood (2008) 1.06
Gene expression regulation and domain function of hematopoietic GATA factors. Semin Cell Dev Biol (2004) 1.01
The AML1-ETO fusion gene promotes extensive self-renewal of human primary erythroid cells. Blood (2002) 0.99
Structure and expression of the human MTG8/ETO gene. Gene (1998) 0.98
Gata1 regulates dendritic-cell development and survival. Blood (2007) 0.95
The Leukemia-associated ETO homologues are differently expressed during hematopoietic differentiation. Exp Hematol (2005) 0.91
AML-1, PU.1, and Sp3 regulate expression of human bactericidal/permeability-increasing protein. Biochem Biophys Res Commun (2003) 0.85
Interactions between the leukaemia-associated ETO homologues of nuclear repressor proteins. Eur J Haematol (2003) 0.84
The human SIN3B corepressor forms a nucleolar complex with leukemia-associated ETO homologues. BMC Mol Biol (2008) 0.80
Persistent malignant stem cells in del(5q) myelodysplasia in remission. N Engl J Med (2010) 2.11
Biosynthesis, processing, and sorting of human myeloperoxidase. Arch Biochem Biophys (2005) 1.58
Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model. Haematologica (2005) 1.51
Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells. Oncogene (2004) 0.93
The involvement of cellular proliferation status in the expression of the human proto-oncogene DEK. Haematologica (2006) 0.93
Mapping of quantitative trait loci controlling timing of bud flush in Salix. Hereditas (2003) 0.91
The Leukemia-associated ETO homologues are differently expressed during hematopoietic differentiation. Exp Hematol (2005) 0.91
Identification of a novel and myeloid specific role of the leukemia-associated fusion protein DEK-NUP214 leading to increased protein synthesis. Genes Chromosomes Cancer (2008) 0.90
Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR. BMC Cancer (2013) 0.89
Functional and biochemical characterization of epithelial bactericidal/permeability-increasing protein. Am J Physiol Gastrointest Liver Physiol (2005) 0.89
Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow. Leuk Res (2007) 0.88
Identification of genes differentially regulated by the P210 BCR/ABL1 fusion oncogene using cDNA microarrays. Exp Hematol (2004) 0.88
The tetraspanin CD63 is involved in granule targeting of neutrophil elastase. Blood (2008) 0.87
The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites. Gene (2005) 0.86
Gene expression analysis of BCR/ABL1-dependent transcriptional response reveals enrichment for genes involved in negative feedback regulation. Genes Chromosomes Cancer (2008) 0.86
The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation. Mol Cancer (2014) 0.86
Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma. BMC Cancer (2012) 0.85
The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase. Exp Cell Res (2009) 0.85
AML-1, PU.1, and Sp3 regulate expression of human bactericidal/permeability-increasing protein. Biochem Biophys Res Commun (2003) 0.85
The Wilms' tumor gene 1 (WT1) induces expression of the N-myc downstream regulated gene 2 (NDRG2). DNA Cell Biol (2007) 0.85
Regulation of the interferon-inducible p53 target gene TRIM22 (Staf50) in human T lymphocyte activation. J Interferon Cytokine Res (2007) 0.84
Interactions between the leukaemia-associated ETO homologues of nuclear repressor proteins. Eur J Haematol (2003) 0.84
A murine antibacterial ortholog to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow. J Leukoc Biol (2004) 0.83
Functional dissociation between proforms and mature forms of proteinase 3, azurocidin, and granzyme B in regulation of granulopoiesis. Exp Hematol (2002) 0.83
Quantitative trait loci controlling cyanogenic glucoside and dry matter content in cassava (Manihot esculenta Crantz) roots. Hereditas (2007) 0.82
Resistance to Melampsora larici-epitea leaf rust in Salix: analyses of quantitative trait loci. J Appl Genet (2008) 0.82
All-trans retinoic acid-induced expression of bactericidal/permeability-increasing protein (BPI) in human myeloid cells correlates to binding of C/EBPbeta and C/EBPepsilon to the BPI promoter. J Leukoc Biol (2006) 0.82
Robust isolation of malignant plasma cells in multiple myeloma. Blood (2014) 0.82
Lentivirus-induced dendritic cells for immunization against high-risk WT1(+) acute myeloid leukemia. Hum Gene Ther (2013) 0.81
The human SIN3B corepressor forms a nucleolar complex with leukemia-associated ETO homologues. BMC Mol Biol (2008) 0.80
Ultranet: efficient solver for the sparse inverse covariance selection problem in gene network modeling. Bioinformatics (2012) 0.80
Transcriptional repression by leukaemia-associated ETO family members can be independent of oligomerization and coexpressed hSIN3B and N-CoR. Biochim Biophys Acta (2008) 0.79
Sorting soluble tumor necrosis factor (TNF) receptor for storage and regulated secretion in hematopoietic cells. J Leukoc Biol (2004) 0.79
The transcriptional co-repressor myeloid translocation gene 16 inhibits glycolysis and stimulates mitochondrial respiration. PLoS One (2013) 0.78
Neutrophil elastase and proteinase 3 trafficking routes in myelomonocytic cells. Exp Cell Res (2010) 0.78
The leukemia associated nuclear corepressor ETO homologue genes MTG16 and MTGR1 are regulated differently in hematopoietic cells. BMC Mol Biol (2012) 0.78
Sorting of Von Willebrand factor to lysosome-related granules of haematopoietic cells. Biochem Biophys Res Commun (2004) 0.78
Neutrophil elastase sorting involves plasma membrane trafficking requiring the C-terminal propeptide. Exp Cell Res (2006) 0.77
Leukemia associated mutant Wilms' tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells. Leuk Res (2013) 0.77
Hematopoietic secretory granules as vehicles for the local delivery of cytokines and soluble cytokine receptors at sites of inflammation. Eur Cytokine Netw (2004) 0.76
DNA-binding dependent and independent functions of WT1 protein during human hematopoiesis. Exp Cell Res (2005) 0.76
Secretory lysosome targeting and induced secretion of human soluble TNF-alpha receptor in murine hematopoietic cells in vivo as a principle for immunoregulation in inflammation and malignancy. Exp Hematol (2009) 0.76
The p53 target gene TRIM22 directly or indirectly interacts with the translation initiation factor eIF4E and inhibits the binding of eIF4E to eIF4G. Biol Cell (2012) 0.76
Artificially controlled aggregation of proteins and targeting in hematopoietic cells. J Leukoc Biol (2003) 0.75
Sorting of neutrophil-specific granule protein human cathelicidin, hCAP-18, when constitutively expressed in myeloid cells. J Leukoc Biol (2002) 0.75
Reactivation of latent Epstein Barr virus infection induces remission of splenic lymphoma with villous lymphocytes. Int J Hematol (2005) 0.75
Granule targeting of soluble tumor necrosis factor (TNF) receptor expressed during granulopoietic maturation in murine bone marrow cells. Eur Cytokine Netw (2006) 0.75
Sorting of soluble TNF-receptor for granule storage in hematopoietic cells as a principle for targeting of selected proteins to inflamed sites. Blood (2003) 0.75
Targeting proteins to secretory lysosomes of natural killer cells as a principle for immunoregulation. Mol Immunol (2003) 0.75